Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema

NCT02684084 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Study revised significantly. New trial to be launched.

Conditions

Diabetic Macular Edema

Interventions

DRUG: Ozurdex
DRUG: Lucentis

Sponsor

North Toronto Eye Care Laser and Eye Specialists

Collaborators

[object Object]